• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Exploring Therapies for Platinum Sensitive & Platinum-Resistant Ovarian Cancer

Opinion
Video

A medical expert discusses efficacy of approaches such as carboplatin doublets, checkpoint inhibitors, and PARP inhibitors for patients with platinum sensitive and platinum-resistant ovarian cancer.

Related Videos
1 expert in this video
5 experts are featured in this series
1 expert in this video
5 experts are featured in this series
Dr Brian Slomovitz
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.